We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+5.47%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$666M
AUM Growth
+$60.8M
(+10%)
Cap. Flow
-$84M
Cap. Flow
% of AUM
-12.6%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
668
New
117
Increased
142
Reduced
187
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United States Oil Fund
USO
|
+$13.8M |
| 2 |
iShares MSCI South Africa ETF
EZA
|
+$12.9M |
| 3 |
iShares MSCI Peru and Global Exposure ETF
EPU
|
+$9.58M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$9.09M |
| 5 |
Nucor
NUE
|
+$8.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$13.2M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$13M |
| 3 |
Walmart Inc
WMT
|
+$12.9M |
| 4 |
Fidelity National Information Services
FIS
|
+$12.6M |
| 5 |
CA
CA, Inc.
CA
|
+$12.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.44% |
| 2 | Industrials | 7.25% |
| 3 | Financials | 6.57% |
| 4 | Technology | 6.24% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AstraZeneca
AZN
$263B
| $8.06M | 1.21% |
+122,638
| New | +$8.02M |
|
27
Waste Management
WM
$95.9B
| $8.02M | 1.2% |
125,858
+125,857
| +12,585,700% | +$8.23M |
|
28
Tyson Foods
TSN
$20.2B
| $8M | 1.2% |
107,129
-87,964
| -45% | -$6.45M |
|
29
Amgen
AMGN
$203B
| $7.94M | 1.19% |
+47,628
| New | +$8.05M |
|
30
Motorola Solutions
MSI
$69.4B
| $7.94M | 1.19% |
104,091
+103,891
| +51,946% | +$7.59M |
|
31
CVS Health
CVS
$137B
| $7.92M | 1.19% |
88,993
+86,997
| +4,359% | +$8.21M |
|
32
Masco
MAS
$16B
| $7.91M | 1.19% |
+230,436
| New | +$7.97M |
|
33
UGI
UGI
$8B
| $7.9M | 1.19% |
+174,720
| New | +$7.97M |
|
34
Air Products & Chemicals
APD
$66.3B
| $7.77M | 1.17% |
+55,882
| New | +$7.75M |
|
35
Clorox
CLX
$11.6B
| $7.72M | 1.16% |
+61,642
| New | +$8.07M |
|
|
36
PUT
United States Oil Fund
USO
$2.45B
| $7.68M | 1.15% |
+4,272
| New | +$359K |
|
37
Mohawk Industries
MHK
$6.9B
| $7.58M | 1.14% |
37,854
+37,853
| +3,785,300% | +$7.78M |
|
38
Fortune Brands Innovations
FBIN
$6.12B
| $7.5M | 1.13% |
151,110
+151,109
| +15,110,900% | +$7.9M |
|
39
Home Depot
HD
$332B
| $7.49M | 1.12% |
58,173
-31,498
| -35% | -$4.2M |
|
|
RSX
40
DELISTED
VanEck Russia ETF
RSX
| $4.71M | 0.71% |
251,184
+195,094
| +348% | +$3.57M |
|
41
CALL
Deutsche Bank
DB
$66.3B
| $4.58M | 0.69% |
+73,601
| New | +$903K |
|
42
Gilead Sciences
GILD
$161B
| $4.53M | 0.68% |
57,315
+39,670
| +225% | +$3.22M |
|
|
CTLT
43
DELISTED
CATALENT, INC.
CTLT
| $4.42M | 0.66% |
171,124
+115,963
| +210% | +$2.88M |
|
44
Southern Company
SO
$110B
| $4.38M | 0.66% |
+85,355
| New | +$4.5M |
|
45
Thermo Fisher Scientific
TMO
$211B
| $4.36M | 0.65% |
27,415
+18,899
| +222% | +$2.91M |
|
46
Labcorp
LH
$24.3B
| $4.34M | 0.65% |
36,742
+25,102
| +216% | +$2.96M |
|
|
B
47
Barrick Mining
B
$62.2B
| $4.01M | 0.6% |
225,355
-5,760
| -2% | -$115K |
|
|
TWTR
48
DELISTED
Twitter, Inc.
TWTR
| $3.98M | 0.6% |
172,780
+36,006
| +26% | +$678K |
|
49
Blackstone
BX
$104B
| $3.7M | 0.56% |
145,065
+31,518
| +28% | +$832K |
|
50
Devon Energy
DVN
$51.9B
| $3.66M | 0.55% |
83,070
+8,085
| +11% | +$328K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2016 Portfolio in Review
As of Q3 2016, Exane Derivatives held 668 positions worth $666M, up 10% from $606M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Exane Derivatives withdrew a net $84M in Q3 2016, closing 44 positions and reducing 187 holdings. Its most notable exit was Walmart Inc, an estimated $12.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 9.4% of assets, up from 5.6% a quarter earlier, followed by Industrials and Financials.
Against the trend, Exane Derivatives opened a new position in iShares MSCI Peru and Global Exposure ETF worth $9.47M.
- Exane Derivatives's largest Q3 2016 buy was iShares MSCI Peru and Global Exposure ETF: 285,227 shares worth $9.47M.
- Exane Derivatives added most to United States Oil Fund in Q3 2016, an estimated $13.8M increase.
- Exane Derivatives's biggest Q3 2016 reduction was Constellation Brands, cutting an estimated $13.2M.
- Exane Derivatives fully exited Walmart Inc in Q3 2016, selling an estimated $12.9M.
- Exane Derivatives's ten largest holdings make up 35% of its $666M portfolio in Q3 2016.
- Exane Derivatives opened 117 new positions and closed 44 in Q3 2016.
- Exane Derivatives's portfolio value rose 10% quarter-over-quarter to $666M.
Based on Exane Derivatives's 13F filing for Q3 2016, filed 26 Oct 2016.